Company NIOX Group Plc

Equities

CIR

GB00BJVD3B28

Pharmaceuticals

Delayed London S.E. 06:24:55 2024-03-28 am EDT 5-day change 1st Jan Change
64 GBX 0.00% Intraday chart for NIOX Group Plc 0.00% -4.48%

Business Summary

NIOX Group plc is a United Kingdom-based diagnostics and management company that is focused on asthma. The Company's product NIOX uses patented technology to measure fractional exhaled nitric oxide (FeNO). Its NIOX FeNO measurement and monitoring products are used by physicians around the globe to help improve asthma diagnosis and management. The Company offers NIOX VERO, a point of care device for the accurate measurement of nitric oxide (NO) as a biomarker of airway inflammation to help diagnose and manage asthma. The device is used by healthcare professionals to improve asthma care, which assists diagnosis, determining responsiveness to inhaled corticosteroids, tailoring inhaled steroid use, monitoring treatment compliance, and reducing the likelihood of exacerbations in at-risk patients compared to traditional monitoring. The Company offers products and services in around 50 countries.

Number of employees: 92

Sales per Business

GBP in Million2021Weight2022Weight Delta
NIOX
100.0 %
28 100.0 % 31 100.0 % +12.19%

Sales per region

GBP in Million2021Weight2022Weight Delta
Asia Pacific
34.2 %
11 38.0 % 11 34.2 % +0.94%
European Union
30.4 %
8 29.4 % 10 30.4 % +15.85%
United States
25.9 %
7 25.4 % 8 25.9 % +14.08%
United Kingdom
8.9 %
2 6.1 % 3 8.9 % +64.71%
Rest of World
0.6 %
0 1.1 % 0 0.6 % -33.33%

Managers

Managers TitleAgeSince
Director of Finance/CFO 59 20-01-08
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer - 19-09-01
Investor Relations Contact - 20-10-31
Human Resources Officer - 14-05-31

Members of the board

Members of the board TitleAgeSince
Chairman 71 19-12-04
Director of Finance/CFO 59 20-01-08
Director/Board Member 67 20-03-01
Chief Operating Officer - 19-09-01
Director/Board Member 60 18-02-07
Director/Board Member 56 18-02-07
Director/Board Member 34 20-11-12

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 422,746,703 193,940,152 ( 45.88 %) 0 45.88 %

Shareholders

NameEquities%Valuation
100,729,255 23.91 % 80 M p
Harwood Capital LLP
18.39 %
77,499,921 18.39 % 61 M p
Woodford Investment Management Ltd.
17.77 %
74,875,647 17.77 % 59 M p
71,065,878 16.87 % 56 M p
Danske Bank A/S (Investment Management)
4.620 %
19,466,493 4.620 % 15 M p
Lombard Odier Asset Management (Europe) Ltd.
4.304 %
18,133,419 4.304 % 14 M p
Invesco Asset Management Ltd.
3.717 %
15,660,000 3.717 % 12 M p
Morgan Stanley Smith Barney LLC (Investment Management)
2.305 %
9,711,000 2.305 % 8 M p
Merchant Capital Manager Ltd.
2.057 %
8,665,409 2.057 % 7 M p
Global Prime Partners Ltd.
1.835 %
7,732,000 1.835 % 6 M p

Company contact information

Niox Group Plc

Hayakawa Building The Oxford Science Park

OX4 4GB, Oxford

+44 18 6540 5560

http://www.niox.com
address NIOX Group Plc(CIR)

Group companies

NameCategory and Sector
Pharmaceuticals: Other

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
0.64 GBP
Average target price
0.76 GBP
Spread / Average Target
+18.75%
Consensus

Annual profits - Rate of surprise